Author - Ruslan Dorfman

DNA

August 2017 Pillcheck update to version GYIAUG212017

While our DNA does not change over time, clinical guidelines established by the scientific community are continuously refined and expanded to cover a growing number of medications. In order to provide a lifetime of Pillcheck value to our customers, we periodically update reports, incorporating the most up-to-date information and [...]

Read more...

Colon cancer treatment and genetic testing for DPYD deficiency

Patients diagnosed with advanced colon cancer have few treatment options besides surgery and aggressive chemotherapy. All chemotherapies are designed to block cell growth. Since all multiplying cells need to replicate their DNA, blocking DNA synthesis stops cell growth. The 5-Fluorouracil (5FU) drug is a modified nucleotide that blocks DNA [...]

Read more...

Your genetics determines the effectiveness of Tecta for you

What is Tecta? How does Tecta work? Tecta (pantoprazole) is prescribed to treat gastrointestinal ulcers, or for gastroesophageal reflux disease (GERD), which includes heartburn and acid reflux, and reflux esophagitis. Tecta is part of a family of drugs called Proton Pump Inhibitors (PPIs). These drugs block Proton Pumps, and reduces stomach [...]

Read more...

I have stars in my genome! Or how genetic variations affect your drug response

How drugs affect the body Many commonly used drugs can be helpful for most while causing adverse reactions in others. Medication needs to be absorbed and then metabolized into a biologically active form or inactivated at a certain rate. Drug absorption and secretion (i.e. pharmacokinetics) can be affected by certain [...]

Read more...